Laparoscopic Extended Pelvic Lymph Node Dissection for Prostate Cancer: Description of the Surgical Technique and Initial Results

European Urology

Volumn 52, Issue 5, 2007, Pages 1347-1357

  Lattouf, Jean Baptiste ^a   Beri, Avi ^a   Jeschke, Stephan ^a   Sega, Wolfgang ^b   Leeb, Karl ^a   Janetschek, Günter ^a  

^a ELISABETHINEN HOSPITAL   (Austria)

^b Krankenhaus der Barmherzigen Schwestern Wien Betriebsgesellschaft   (Austria)

Author keywords

Laparoscopy; Lymph node excision; Neoplasm staging; Prostatectomy; Prostatic neoplasms

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ARTICLE; CANCER LOCALIZATION; CLINICAL ARTICLE; CONTROLLED STUDY; DEEP VEIN THROMBOSIS; FOLLOW UP; HUMAN; HUMAN TISSUE; LAPAROSCOPIC SURGERY; LYMPH NODE METASTASIS; LYMPHOCELE; MALE; OBTURATOR NERVE; OPERATION DURATION; PELVIS LYMPHADENECTOMY; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATECTOMY; SURGICAL TECHNIQUE;

AGED; BIOPSY; FOLLOW-UP STUDIES; HUMANS; LAPAROSCOPY; LYMPH NODE EXCISION; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PELVIS; PROSTATIC NEOPLASMS; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 34548831345     PISSN: 03022838     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.eururo.2007.04.073     Document Type: Article

References (30)

1. Fowler J.E., and Whitmore Jr. W.F. The incidence and extent of pelvic lymph node metastasis in apparently localized prostate cancer. Cancer 47 (1981) 2941-2945
2. McDowel II C.G., Johnson J.W., Tenney D.M., and Johnson D.E. Pelvic lymphadenectomy for staging clinically localized prostate cancer: indications, complications, and results in 217 cases. Urology 35 (1990) 476-482
3. Partin A.W., Yoo J., Carter H.B., et al. The use of prostate specific antigen, clinical stage and Gleason score to predict pathological stage in men with localized prostate cancer. J Urol 150 (1993) 110-114
4. Bluestein D.L., Bostwick D.G., Bergstralh E.J., and Oesterling J.E. Eliminating the need for bilateral pelvic lymphadenectomy in select patients with prostate cancer. J Urol 151 (1994) 1315-1320
5. Petros J.A., and Catalona W.J. Lower incidence of unsuspected lymph node metastases in 521 consecutive patients with clinically localized prostate cancer. J Urol 147 (1992) 1574-1575
6. Danella J.F., Dekernion J.B., Smith R.B., and Steckel J. The contemporary incidence of lymph node metastases in prostate cancer: implications for laparoscopic lymph node dissection. J Urol 149 (1993) 1488-1491
7. Raghavaiah N.V., and Jordan Jr. W.P. Prostatic lymphography. J Urol 121 (1979) 178-181
8. Bader P., Buckhard F.C., Markwalder R., and Studer U.E. Is a limited lymph node dissection an adequate staging procedure for prostate cancer?. J Urol 168 (2002) 514-518
9. Allaf M.E., Palapattu G.S., Trock B.J., Carter H.B., and Walsh P.C. Anatomical extent of lymph node dissection: impact on men with clinically localized prostate cancer. J Urol 172 (2004) 1840-1844
10. Weckermann D., Goppelt M., Dorn R., Wawroschek F., and Harzmann R. Incidence of positive pelvic lymph nodes in patients with prostate cancer, a prostate-specific antigen (PSA) level of < or =10 ng/mL and biopsy Gleason score of < or =6, and their influence on PSA progression-free survival after radical prostatectomy. BJU Int 97 (2006) 1173-1178
11. Zincke H., Utz D.C., Myers R.P., Farrow G.M., Patterson D.E., and Furlow W.L. Bilateral pelvic lymphadenectomy and radical retropubic prostatectomy for adenocarcinoma of prostate with regional lymph node involvement. Urology 19 (1982) 238-247
12. Bader P., Burkhard F.C., Markwalder R., and Studer U.E. Disease progression and survival of patients with positive lymph nodes after radical prostatectomy. Is there a chance of cure?. J Urol 169 (2003) 849-854
13. Schmid H.P., Mihatsch M.J., Hering F., and Rutishauser G. Impact of minimal lymph node metastasis on long-term prognosis after radical prostatectomy. Eur Urol 31 (1997) 11-16
14. Cheng L., Zincke H., Blute M.L., Bergstralh E.J., Scherer B., and Bostwick D.G. Risk of prostate carcinoma death in patients with lymph node metastasis. Cancer 91 (2001) 66-73
15. Joslyn S.A., and Konety B.R. Impact of extent of lymphadenectomy on survival after radical prostatectomy for prostate cancer. Urology 68 (2006) 121-125
16. Gershman A., Daykhovsky L., Chandra M., Danoff D., and Grundfest W.S. Laparoscopic pelvic lymphadenectomy. J Laparoendosc Surg 1 (1990) 63-68
17. Griffith D.P., Schuessler W.W., Nickell K.G., and Meaney J.T. Laparoscopic pelvic lymphadenectomy for prostatic adenocarcinoma. Urol Clin North Am 19 (1992) 407-415
18. Beer M., Staehler G., and Dorsam J. Laparoscopic pelvic lymphadenectomy. Indications, technique, initial results. Chirurg 62 (1991) 340-344
19. Jeschke S., Nambirajan T., Leeb K., Ziegerhofer J., Sega W., and Janetschek G. Detection of early lymph node metastases in prostate cancer by laparoscopic radioisotope guided sentinel lymph node dissection. J Urol 173 (2005) 1943-1946
20. Amling C.L., Bergstralh L.H., Blute M.L., Slezak J.M., and Zincke H. Defining prostate specific antigen progression after radical prostatectomy: what is the most appropriate cut point?. J Urol 165 (2003) 1146-1151
21. Simmons M.N., Stephenson A.J., and Klein E.A. Natural history of biochemical recurrence after radical prostatectomy: risk assessment for secondary therapy. Eur Urol 51 (2007) 1175-1184
22. Stephenson A.J., Kattan M.W., Eastham J.A., et al. Defining biochemical recurrence of prostate cancer after radical prostatectomy: a proposal for a standardized definition. J Clin Oncol 24 (2006) 3973-3978
23. Bishoff J.T., Reyes A., Thompson I.M., et al. Pelvic lymphadenectomy can be omitted in selected patients with carcinoma of the prostate: development of a system of patient selection. Urology 45 (1995) 270-274
24. Partin A.W., Kattan K.W., Subong E.N., et al. Combination of prostate-specific antigen, clinical stage, and Gleason score to predict pathological stage of localized prostate cancer. A multi-institutional update. JAMA 277 (1998) 1445-1451
25. Campbell S.C., Klein E.A., Levin H.S., and Piedmonte M.R. Open pelvic lymph node dissection for prostate cancer: a reassessment. Urology 46 (1995) 352-355
26. Bhatta-Dhar N., Reuther A.M., Zippe C., and Klein E.A. No difference in six-year biochemical failure rates with or without pelvic lymph node dissection during radical prostatectomy in low-risk patients with localized prostate cancer. Urology 63 (2004) 528-531
27. Heidenreich A., Varga Z., and VonKnobloch R. Extended pelvic lymphadenectomy in patients undergoing radical prostatectomy: high incidence of lymph node metastasis. J Urol 167 (2002) 1681-1686
28. Briganti A., Chun F.K.-H., Salonia A., et al. Complications and other surgical outcomes associated with extended pelvic lymphadenectomy in men with localized prostate cancer. Eur Urol 50 (2006) 1006-1013
29. Touijer K., and Guillonneau B. Laparoscopic radical prostatectomy: a critical analysis of surgical quality. Eur Urol 49 (2006) 625-632
30. Wyler S.F., Sulser T., Seifert H.H., et al. Laparoscopic extended pelvic lymph node dissection for high risk prostate cancer. Urology 68 (2006) 883-887